Pantozol Control (Pantoprazole)

Pantoprazole, the active ingredient in Pantozol Control, is a proton pump inhibitor presented as a strength/form for oral use. It reduces gastric acid secretion and is indicated for conditions such as GERD, erosive esophagitis, Zollinger‑Ellison syndrome and NSAID‑induced ulcer prophylaxis in adults.

GNH USA supplies Pantozol Control as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazole is a proton pump inhibitor used to manage acid‑related gastrointestinal disorders. - Gastroesophageal reflux disease (GERD): provides symptomatic relief and promotes healing of the esophageal lining. - Erosive esophagitis: accelerates mucosal healing and reduces further erosion. - Zollinger‑Ellison syndrome: controls excessive gastric acid production associated with gastrin‑secreting tumours. - NSAID‑induced ulcer prophylaxis: lowers the risk of ulcer formation in patients requiring long‑term NSAID therapy.

Pantoprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: usually self‑limiting. - Abdominal pain or discomfort. - Nausea or vomiting. - Flatulence or bloating. - Constipation.

Serious or Rare Side Effects: - Severe allergic reactions (e.g., anaphylaxis, angioedema). - Clostridioides difficile‑associated colitis. - Low magnesium levels (hypomagnesemia) with prolonged use. - Acute interstitial nephritis. - Fracture risk with long‑term high‑dose therapy. - Liver enzyme elevations indicating possible hepatitis.

Before starting Pantozol Control, consider the following safety points: - Assess renal function: dose adjustment may be needed in severe impairment. - Review hepatic status: use with caution in moderate to severe liver disease. - Monitor for infections: prolonged acid suppression can increase risk of gastrointestinal infections. - Evaluate bone health: long‑term therapy may affect calcium absorption. - Pregnancy and lactation: prescribe only if the benefit outweighs potential risk. - Store at ambient temperature: keep below 25°C, retain in original packaging and protect from moisture.

Pantoprazole can affect the absorption or metabolism of several co‑administered medicines.

Major Interactions (Avoid): - Antifungal agents (ketoconazole, itraconazole): reduced absorption due to higher gastric pH. - HIV protease inhibitors (atazanavir, nelfinavir): decreased plasma concentrations. - Clopidogrel: diminished antiplatelet effect.

Moderate Interactions (Monitor Closely): - Warfarin: potential increase in INR; monitor coagulation parameters. - Methotrexate: reduced renal clearance may raise serum levels. - Digoxin: slight increase in serum concentration; observe for toxicity signs.